Mifepristone, a common abortion-inducing drug, will remain on the market without additional restrictions while a legal challenge proceeds, the U.S. Supreme Court ruled Friday.
The unsigned, one-paragraph court ruling stayed the lower court’s ruling, with Justice Clarence Thomas and Justice Samuel Alito dissenting.